Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
13 Results
Available On-Demand
AGT, has a broad viral vector delivery platform evolved over ten years of advanced development. AGT…
CohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and…
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) is a biopharmaceutical company…
Elpiscience is a clinical stage biopharmaceutical company focusing on cancer immunotherapy. The…
Exopharm Limited (ASX:EX1) is a clinical-stage Australian biotechnology company developing…
Geistlich Pharma, a family-owned Swiss company, is a world leader in the field of biomaterials and…
MaxCyte is a clinical-stage global cell-based therapies and life sciences company. As the inventors…
Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel…
Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic…
Primary Peptides Inc is a clinical-stage targeted protein degradation platform technology company…
Revelation is a clinical stage life sciences company focused on the development of immunologic…
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and…
XyloCor Therapeutics is focused on the development of novel gene therapy for unmet needs in…